(102 days)
No
The description focuses on standard oscillometric blood pressure measurement, irregular heartbeat detection based on interval variation, and Bluetooth data transmission. There is no mention of AI, ML, or any algorithms that learn or adapt from data.
No
The device is a blood pressure monitor designed for measurement and monitoring, not for providing therapy or treatment.
Yes
This device measures blood pressure and heart rate, detects irregular heartbeats, and provides a risk category indicator, all of which are used to aid in the diagnosis or detection of a disease or condition.
No
The device description clearly indicates it is a physical blood pressure monitor that uses the oscillometric method with a cuff and LCD panel, in addition to having Bluetooth data transmission capabilities. It is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- Device Function: The HL858CP is a blood pressure monitor that measures physiological parameters (blood pressure and heart rate) directly from the human body using a cuff on the upper arm. It does not analyze specimens taken from the body.
- Intended Use: The intended use is for measuring blood pressure and heart rate in adults at home. This is a direct physiological measurement, not an in vitro test.
Therefore, the HL858CP falls under the category of a non-invasive physiological monitoring device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
HL858CP automatically measures human's Systolic blood pressure and heart rate by using the oscillometric method during inflation. All values can be read out in one LCD panel. Measurement position is at human being's upper arm. The intended use of this over-the-counter device is for adults aged 18 years and older with arm circumference ranging from 9 inches to 22 inches (approx.23 cm to 56 cm) and for home use.
The device can accurately measure in pregnant patients including those with known or suspected in preeclampsia condition.
HL858CP detects the appearance of irregular heartbeats during measurement; an indicated symbol will appear with measuring reading. And the Risk Category Indicator will show the information with the readings on the user tracking their blood pressure level.
Besides, the device features a built-in "Bluetooth Data Transmission" function, which enables the device automatically transmit measuring results to paired Bluetooth-enabled device. Also, users could simply synchronize the current date and time, and check the battery status of blood pressure monitor by means of DailyChek® application software with the paired Bluetooth-enabled device.
Product codes
DXN
Device Description
HL858CP automatically measures human's Systolic, Diastolic blood pressure and heart rate by using the oscillometric method during inflation. All values can be read out in one LCD panel. Measurement position is at human being's upper arm. The intended use of this over-the-counter device is for adults aged 18 years and older with arm circumference ranging from 9 inches to 22 inches (approx.23 cm to 56 cm) and for home use. The device can accurately measure blood pressure in pregnant patients including those with known or suspected in pre-eclampsia condition.
The device will display a symbol O-W- to indicate the detection of irregular heartbeat rhythm as defined as a rhythm is more than or less than 25% from the average heartbeat intervals during the measurement. Additionally, after measurement, the Risk Category Indicator function will show the information with the readings on the screen for the user tracking their blood pressure level.
Besides, when Triple Check mode is turned on by user, the symbol ) will display on the LCD. Then press Start/Stop button the device will take three consecutive measurements automatically at 1 minute intervals. After measurements are completed LCD will display the average values of the three measurements.
HL858CP is equipped with Bluetooth Data Transmission function, which can electronic transfer the measured data of HL858CP to the paired Bluetooth-enabled device. The transferable measured data includes Systolic, Diastolic, and Pulse. The Bluetooth Data Transmission is without controlling or altering the functions or parameters of HL858CP and Paired Bluetooth-enabled device. In addition, the Bluetooth Data Transmission function could transfer the battery status of HL858CP to the Paired Bluetooth-enabled device without any controlling or altering on both devices.
Besides, Bluetooth Data Transmission function could provide Date/Time synchronization for HL858CP, which simply help users set Time/ Date information. It will help users prevent from entering incorrect time information.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human being's upper arm
Indicated Patient Age Range
adults aged 18 years and older
Intended User / Care Setting
home use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
HL858CP, which includes the Universal cuff and Extra Large cuff, is compliant to the standard of ISO 81060-2: Second Edition 2013-05-01 Non-invasive sphygmomanometers- Part 2: Clinical validation of automated measurement type. The results of this clinical investigation show that the required limits for mean difference and standard deviation are fulfilled by the subject device HL858CP in the group of 90 subjects with qualified distribution. Thus, all the relevant activities were performed by designate individual(s) and the results demonstrated that the predetermined acceptance criteria were fully met.
The subject device HL858CP featured the pregnancy accuracy which intended population is the same as the predicate device Microlife Upper Arm Automatic Digital Blood Pressure Monitor (K153077). In addition, the clinical test result of HL858CP meets criteria of ISO 81060-2:2013 and proves the safety and effectiveness of pregnancy accuracy performed as well as the predicate device Microlife Upper Arm Automatic Digital Blood Pressure Monitor (K153077).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA name and title on the right. The symbol on the left is a stylized representation of a human figure, while the text on the right reads "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue letters.
June 12, 2020
Health & Life Co., Ltd Simon Lee RA/QA Div. Deputy Manager 9F, No. 186 Jian Yi Road, Zhonghe District, New Taipei City, 23553 Taiwan
Re: K200521
Trade/Device Name: Full Automatic(NIBP) Blood Pressure Monitor, Model HL858CP Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: May 14, 2020 Received: May 15, 2020
Dear Simon Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
LT Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name
Full Automatic (NIBP) Blood Pressure Monitor, Model HL858CP
Indications for Use (Describe)
HL858CP automatically measures human's Systolic blood pressure and heart rate by using the oscillometric method during inflation. All values can be read out in one LCD panel. Measurement position is at human being's upper arm. The intended use of this over-the-counter device is for adults aged 18 years and older with arm circumference ranging from 9 inches to 22 inches (approx.23 cm to 56 cm) and for home use.
The device can accurately measure in pregnant patients including those with known or suspected in preeclampsia condition.
HL858CP detects the appearance of irregular heartbeats during measurement; an indicated symbol will appear with measuring reading. And the Risk Category Indicator will show the information with the readings on the user tracking their blood pressure level.
Besides, the device features a built-in "Bluetooth Data Transmission" function, which enables the device automatically transmit measuring results to paired Bluetooth-enabled device. Also, users could simply synchronize the current date and time, and check the battery status of blood pressure monitor by means of DailyChek® application software with the paired Bluetooth-enabled device.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
PREMARKET NOTIFICATION
510(k) SUMMARY
(As Required By 21 CFR 807.92)
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is: _______________________________________________________________________________________________________________________________________________ Date: ________________________________________________________________________________________________________________________________________________________________________
1. Submitter:
Health & Life Co., Ltd. 9F. No.186, Jian Yi Road, Zhonghe District, New Taipei City, Taiwan, R.O.C TEL: +886-2-8227-1300 FAX: +886-2-8227-1301
Contact person: Simon Lee/ RA & QA Deputy Manager. E-mail: simon.l@hlmt.com.tw Tel: 886-2-8227-1300 ext.1205 Fax: 886-2-8227-1301
2. Name of the Device:
Trade Name: Full Automatic (NIBP) Blood Pressure Monitor, Model HL858CP Common Name: Blood Pressure Monitor Classification Name: Non-invasive Blood Pressure Measurement System Classification: Class II, 21 CFR 870.1130 Classification Panel: 74 Cardiovascular Product Code: DXN
3. Information for the 510(k) Cleared Device (Predicate Device):
A. Full Automatic (NIBP) Blood Pressure Monitor, Model: HL858CL (K190507) B. Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model: BP3MW1-4B (K153077)
4
4. Device Description:
HL858CP automatically measures human's Systolic, Diastolic blood pressure and heart rate by using the oscillometric method during inflation. All values can be read out in one LCD panel. Measurement position is at human being's upper arm. The intended use of this over-the-counter device is for adults aged 18 years and older with arm circumference ranging from 9 inches to 22 inches (approx.23 cm to 56 cm) and for home use. The device can accurately measure blood pressure in pregnant patients including those with known or suspected in pre-eclampsia condition.
The device will display a symbol O-W- to indicate the detection of irregular heartbeat rhythm as defined as a rhythm is more than or less than 25% from the average heartbeat intervals during the measurement. Additionally, after measurement, the Risk Category Indicator function will show the information with the readings on the screen for the user tracking their blood pressure level.
Besides, when Triple Check mode is turned on by user, the symbol ) will display on the LCD. Then press Start/Stop button the device will take three consecutive measurements automatically at 1 minute intervals. After measurements are completed LCD will display the average values of the three measurements.
HL858CP is equipped with Bluetooth Data Transmission function, which can electronic transfer the measured data of HL858CP to the paired Bluetooth-enabled device. The transferable measured data includes Systolic, Diastolic, and Pulse. The Bluetooth Data Transmission is without controlling or altering the functions or parameters of HL858CP and Paired Bluetooth-enabled device. In addition, the Bluetooth Data Transmission function could transfer the battery status of HL858CP to the Paired Bluetooth-enabled device without any controlling or altering on both devices.
Besides, Bluetooth Data Transmission function could provide Date/Time synchronization for HL858CP, which simply help users set Time/ Date information. It will help users prevent from entering incorrect time information.
5. Intended Use
HL858CP automatically measures human's Systolic, Diastolic blood pressure and heart rate by using the oscillometric method during inflation. All values can be read out in one LCD panel. Measurement position is at human being's upper arm. The
5-2
5
intended use of this over-the-counter device is for adults aged 18 years and older with arm circumference ranging from 9 inches to 22 inches (approx.23 cm to 56 cm) and for home use.
The device can accurately measure blood pressure in pregnant patients including those with known or suspected in pre-eclampsia condition.
HL858CP detects the appearance of irregular heartbeats during measurement; an indicated symbol will appear with measuring reading. And the Risk Category Indicator will show the information with the readings on the screen for the user tracking their blood pressure level.
Besides, the device features a built-in "Bluetooth Data Transmission" function, which enables the device automatically transmit measuring results to paired Bluetooth-enabled device. Also, users could simply synchronize the current date and time, and check the battery status of blood pressure monitor by means of DailyChek® application software with the paired Bluetooth-enabled device.
| Item | Predicate Device
HL858CL (K190507) | Subject Device
HL858CP |
|--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------|
| Method of
measurement | Oscillimetric | Same as left |
| Measurement
Type | During inflation | Same as left |
| Range of
measurement | Pressure 0- 300mmHg,
Rated Range of Determination:
40280mmHg,5mmHg/sec.
Pulse 40-199 Beats/minute | Same as left |
| Accuracy | Pressure ± 3mmHg
Pulse ± 5% | Same as left |
| Pressure
Changed Rate | 2
(from 90mmHg to 150mmHg) | Same as left |
| Display | Liquid Crystal Digital | Same as left |
| Power Supply | 6V 1A, 4 × AA/1.5V (LR6) Alkaline
batteries, or
AC Adapter (Model: SINPRO,
HPU15-102 Input: 100-240V AC
47-63Hz / Output: 5.99V, DC, 2A) | Same as left |
| Storage/
Transportation
Environment | - 25°C ~ +60°C (- 13°F~
+140°F),
≤ 93% R.H. | - 25°C ~ +50°C (- 13°F~
+122°F),
≤ 93% R.H. |
| Operating
Environment | 5°C ~ 40°C (41°F104°F),1060hPa | Same as left |
15% ~ 93% R.H.
700
| Material | ABS housing and
ABS keys | Same as left |
| Sets of memory | 2*120, total 240 | Same as left |
| Number of
Push Button | 6+1 switch control
(Start/Stop, Memory (M), User
Select, Bluetooth ( ), Date/Time
( ), AM/PM button; Triple Check
slider) | Same as left |
| Storage pouch | No | Same as left |
| Cuff size | Arm circumference approx.
23-43 cm / approx.9~17
inches(Universal Cuff)
43 ~ 56 cm / approx.17 ~ 22
inch(Extra Large Cuff) | Same as left |
| Unit Weight | Approx. 330 ± 5g
(Excluding cuff and
Batteries ) | Same as left |
| Unit
Dimensions | 118×163.8×48mm (L×W×H) | Same as left |
| Risk Category
Indicator | Yes
(Risk Category Indicator, Five
Levels) | Same as left |
| Irregular
Heartbeat
Detector | Yes
(Irregular Heartbeat
Detection) | Same as left |
| Triple-Check
(Multi-Read)
Function | Yes | Same as left |
| Bluetooth Data
Transmission | 1. Measurement Data
Transmission
2. Date/Time
Synchronization
3. Battery Status Check | Same as left |
| Battery Life | $\geq$ 250 times | Same as left |
| Intended
patients
population
(Pregnant
Accuracy) | No | Yes |
| Error symbol | EE / E1 / E2 / E3 / E4 /
Excessive Body Motion
Detector | Same as left |
| Accessories | Arm cuff with tube: 23 ~ 43 cm / approx.9 ~ 17 inches
(Universal cuff), 43 ~ 56 cm / approx.17 ~ 22 inches (Extra
Large cuff), 4AA/1.5V (LR6)
alkaline batteries, 5.99V DC
AC Adaptor, instruction
manual, gift box. | Same as left |
6. Comparison of device to predicate device:
Product Specification Comparison Table of Subject Device HL858CP, and Predicate Device HL858CL (K190507)
6
7
Changes from the predicate devices HL858CL (K190507):
-
Add intended population for pregnant accuracy.
-
Revise the upper temperature limit of Storage/ Transportation Environment.
These features have been verified and validated and do not affect the safety and effectiveness of subject device HL858CP. As for the newly added pregnant patient population (including those with known or suspected in pre-eclampsia condition) to the subject device HL858CP, was compared with the other predicate device Microlife BP3MW1-4B (K153077). Please refer to Section 12. Substantial Equivalence Discussion for detail information. In addition, the clinical investigation record please refer to Section 20. Performance Testing- Clinical.
8
7. Discussion of Clinical Tests Performed:
HL858CP, which includes the Universal cuff and Extra Large cuff, is compliant to the standard of ISO 81060-2: Second Edition 2013-05-01 Non-invasive sphygmomanometers- Part 2: Clinical validation of automated measurement type. The results of this clinical investigation show that the required limits for mean difference and standard deviation are fulfilled by the subject device HL858CP in the group of 90 subjects with qualified distribution. Thus, all the relevant activities were performed by designate individual(s) and the results demonstrated that the predetermined acceptance criteria were fully met.
The subject device HL858CP featured the pregnancy accuracy which intended population is the same as the predicate device Microlife Upper Arm Automatic Digital Blood Pressure Monitor (K153077). In addition, the clinical test result of HL858CP meets criteria of ISO 81060-2:2013 and proves the safety and effectiveness of pregnancy accuracy performed as well as the predicate device Microlife Upper Arm Automatic Digital Blood Pressure Monitor (K153077).
8. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence is as follows:
The subject device was tested to evaluate its safety and effectiveness, including the followings:
- a. EMC Test: IEC 60601-1-2 Edition 4:2014, Medical Electrical Equipment Part 1-2: General requirements for safety - collateral standard: Electromagnetic compatibility - Requirements and Tests
- b. Safety Test:
-IEC 60601-1:2005, Medical electrical equipment - Part 1: General requirements for basic safety and essential performance
-IEC 60601-1-11:2015, Medical electrical equipment-Part 1-11: General Requirement for basic safety and essential performance- Collateral Standard: Requirements for medical electrical systems used in the home healthcare environment
-
c. FCC Test:
FCC 47 CFR Part 15, Subpart B, C -
d. Biocompatibility Test:
-ISO 10993-1:2009, Biological evaluation of medical devices- Part 1: Evaluation and testing within a risk management process
9
-ISO 10993-5:2009, Biological evaluation of medical devices-Part 5: Tests for In Vitro cytotoxicity
-ISO 10993-10:2010, Third Edition Biological evaluation of medical devices-Part 10: Tests for irritation and skin sensitization
e. Reliability Test:
IEC 80601-2-30 Edition 2 2018-03 Medical electricalequipment-Part 2-30: Particular requirements for the basic safety and essential performance of automated non-invasive sphygmomanometers.
- f. Risk Assessment: ISO 14971:2007 Second Edition, Medical devices -Application of risk management to medical devices
g. Software Verification and Validation:
-IEC 62304 Ed.1.1:2006+A1:2015, Medical device software - Software life cycle processes,
-IEC 60601-1-4 Medical electrical equipment - Part 1-4: General requirements for safety - Collateral standard: Programmable electrical medical systems, edition 1.1
h. Usability Validation:
-IEC 62366-1:2015 Medical devices - Application of usability engineering to medical devices
-IEC 60601-1-6:2013 Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
9. Conclusions:
The subject device was tested and fulfilled the requirements of those standards mentioned above, and it has concluded that the subject device is substantially equivalent to the predicate device.